Lewes, DE -- (SBWIRE) -- 01/25/2013 -- Report provides value (USD million) data for all the market categories i.e. Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture.
Inquire about this report: Asia-Pacific in Vitro Diagnostics Market Outlook to 2018
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts, which also provides company shares and distribution shares data for each of the aforementioned market categories, and is also provides global corporate-level profiles of the key market participants.
It also gives key data on annualized market revenues (USD million) for each of the market categories in each of the country which includes information from 2004 to 2011, forecast forward for 7 years to 2018.
Benefits of this report
“In Vitro Diagnostics Market forecast on Asia-Pacific countries (Australia, China, India and Japan)-2018” report is specifically useful to develop business strategies by identifying the key market categories and segments poised for strong growth, develop market-entry and market expansion strategies, design competition strategies by identifying who-stands-where in the Asia-Pacific In Vitro Diagnostics competitive landscape, develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future, and to identify, understand and capitalize the key distribution channels and what's the most preferred mode of product distribution.
The report also includes key data of major players which include F. Hoffmann-La Roche Ltd., Siemens Healthcare, Abbott Laboratories, Sysmex Corporation, Beckman Coulter, Inc., and Ortho-Clinical Diagnostics Inc. Becton, Dickinson and Company, Bio-Rad Laboratories, Inc, bioMerieux S.A, Eiken Chemical Co Ltd, and Shanghai Kehua Bio-e.
Contact us for Custom Market Research Requirements.